Sanika Chirwa to HIV Infections
This is a "connection" page, showing publications Sanika Chirwa has written about HIV Infections.
Connection Strength
0.174
-
Desta Z, Gammal RS, Gong L, Whirl-Carrillo M, Gaur AH, Sukasem C, Hockings J, Myers A, Swart M, Tyndale RF, Masimirembwa C, Iwuchukwu OF, Chirwa S, Lennox J, Gaedigk A, Klein TE, Haas DW. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2B6 and Efavirenz-Containing Antiretroviral Therapy. Clin Pharmacol Ther. 2019 10; 106(4):726-733.
Score: 0.064
-
Leger P, Chirwa S, Nwogu JN, Turner M, Richardson DM, Baker P, Leonard M, Erdem H, Olson L, Haas DW. Race/ethnicity difference in the pharmacogenetics of bilirubin-related atazanavir discontinuation. Pharmacogenet Genomics. 2018 Jan; 28(1):1-6.
Score: 0.058
-
Munkombwe D, Muungo TL, Michelo C, Kelly P, Chirwa S, Filteau S. Lipid-based nutrient supplements containing vitamins and minerals attenuate renal electrolyte loss in HIV/AIDS patients starting antiretroviral therapy: A randomized controlled trial in Zambia. Clin Nutr ESPEN. 2016 06; 13:e8-e14.
Score: 0.051